Volume 12, Number 11—November 2006
Research
Seroprevalence of Hepatitis E Virus Infection, Rural Southern People’s Republic of China
Rong-Cheng Li*1, Sheng-Xiang Ge†1, Yan-Ping Li*, Ying-Jie Zheng†2, Yi Nong*, Qing-Shun Guo†, Jun Zhang†, Mun-Hon Ng†, and Ning-Shao Xia†
Table 2
IgG anti–hepatitis E virus (HEV) seroprevalence in rural communities, southern China, 2003
| Communities | Participants | IgG anti-HEV seroprevalence (%)* | |
|---|---|---|---|
| Observed | Standardized | ||
| Linyun | 1,047 | 58.4 | 66.1 |
| Xin'an | 1,037 | 60.4 | 59.4 |
| Guilin | 542 | 57.8 | 49.4 |
| Luochen | 981 | 42.2 | 42.6 |
| Tiendan | 377 | 45.6 | 38.8 |
| Binyan | 1,106 | 31.1 | 36.2 |
| Linshan | 1,230 | 21.0 | 25.2 |
| Liuzhen | 964 | 43.1 | 30.4 |
| Total | 7,284 | 43.3 | 43.5 |
| Male | 3,440 | 45.8 | 47.1 |
| Female | 3,844 | 41.0 | 39.7
*Seroprevalence standardized according to People's Republic of China national census of 2000; IgG, immunoglobulin G. |
*Seroprevalence standardized according to People's Republic of China national census of 2000; IgG, immunoglobulin G.
1Dr. Rong-Cheng Li and Dr. Sheng-Xiang Ge contributed equally to this paper.
2Current affiliation: Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China.
Page created: October 14, 2011
Page updated: October 14, 2011
Page reviewed: October 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.